Predict your next investment

HEALTHCARE | Drug Discovery
nugeninc.com

See what CB Insights has to offer

Total Raised

$39.43M

Investors Count

12

Deal Terms

6

NuGEN Technologies Funding, NuGEN Technologies Valuation & NuGEN Technologies Revenue

10 Fundings

NuGEN Technologies's latest funding round was a Acquired for on August 16, 2018.

NuGEN Technologies's valuation in August 2011 was $52.62M.

NuGEN Technologies's latest post-money valuation is from August 2018.

Sign up for a free trial to see NuGEN Technologies's valuations in August 2018, March 2010, March 2006 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/16/2018

Acquired

$99M

3

9/26/2014

Debt

$6.18M

Undisclosed Investors

1

8/29/2011

Series E - II

$3.5M

$52.62M

3/5/2010

Series E

$99M

$99M

0

3/8/2006

Series D

$99M

$99M

0

Date

8/16/2018

9/26/2014

8/29/2011

3/5/2010

3/8/2006

Round

Acquired

Debt

Series E - II

Series E

Series D

Amount

$6.18M

$3.5M

$99M

$99M

Investors

Undisclosed Investors

Valuation

$99M

$52.62M

$99M

$99M

Revenue

Sources

3

1

0

0

NuGEN Technologies Deal Terms

6 Deal Terms

NuGEN Technologies's deal structure is available for 6 funding rounds, including their Acquired from August 16, 2018.

Round

Acquired

Series E - II

Series E

Series D

Series B

Funding Date

$99M

$99M

$99M

$99M

$99M

Pre-Money Valuation

$99M

$99M

$99M

Post-Money Valuation

$99M

$99M

$99M

$99M

Amount Raised

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Series E - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series E

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series D

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

NuGEN Technologies Investors

12 Investors

NuGEN Technologies has 12 investors. Tecan invested in NuGEN Technologies's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/16/2018

8/16/2018

1
Acquired

Corporation

Switzerland

8/25/2003

8/29/2011

4
Series C, Series D (2006), Series E (2010), Series E - II (2011)

Venture Capital

California

3/8/2006

8/29/2011

3
Series D, Series E (2010), Series E - II (2011)

Michael Hunkapiller

Venture Capital

California

00/00/0000

00/00/0000

Band of Angels

Subscribe to see more

Angel Investor (Group)

California

00/00/0000

00/00/0000

Radius Ventures

Subscribe to see more

Venture Capital

New York

First funding

8/16/2018

8/25/2003

3/8/2006

00/00/0000

00/00/0000

Last Funding

8/16/2018

8/29/2011

8/29/2011

00/00/0000

00/00/0000

Investor

Band of Angels

Radius Ventures

Rounds

1
Acquired
4
Series C, Series D (2006), Series E (2010), Series E - II (2011)
3
Series D, Series E (2010), Series E - II (2011)

Subscribe to see more

Subscribe to see more

Board Seats

Michael Hunkapiller

Type

Corporation

Venture Capital

Venture Capital

Angel Investor (Group)

Venture Capital

Location

Switzerland

California

California

California

New York

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.